| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.01 | 1 |